Zimmer Biomet (Formerly Known As Biomet Inc.)
56 East Bell Drive
Warsaw
Indiana
46582
United States
Tel: 574-267-6639
Fax: 574-267-8137
Website: http://www.zimmerbiomet.com/
440 articles about Zimmer Biomet (Formerly Known As Biomet Inc.)
-
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2022
5/17/2022
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2022.
-
Zimmer Biomet Announces Appointment of New Chief Accounting Officer
5/16/2022
Zimmer Biomet Holdings, Inc., a global medical technology leader, announced the appointment of Paul Stellato as Vice President, Controller and Chief Accounting Officer.
-
Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni™ Suite Intelligent Operating Room
5/10/2022
Zimmer Biomet Holdings, Inc., a global medical technology leader, introduced the availability of new artificial intelligence¹ capabilities within Omni™ Suite, an intelligent operating room designed to optimize surgical workflow and procedural efficiency by automating manual tasks and streamlining unnecessary technology and redundant hardware.
-
Zimmer Biomet Announces First Quarter 2022 Financial Results
5/3/2022
Zimmer Biomet Holdings, Inc. reported financial results for the quarter ended March 31, 2022.
-
Zimmer Biomet to Present at the BofA Securities Healthcare Conference
4/27/2022
Zimmer Biomet Holdings, Inc. announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the BofA Securities Healthcare Conference on Wednesday, May 11, 2022, at 5:00 p.m. Eastern Time.
-
Extremity Medical Files Patent Infringement Lawsuit Against Nextremity Solutions, Zimmer Biomet Holdings and Zimmer, Inc.
4/6/2022
Extremity Medical, LLC announced today that it filed a lawsuit against Nextremity Solutions, Inc.; Zimmer Biomet Holdings, Inc.; and Zimmer, Inc., alleging infringement of an Extremity Medical patent* for its intraosseous fixation platform arising from the marketing of the InCore Lapidus System by these companies.
-
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2022 Financial Results
4/5/2022
Zimmer Biomet Holdings, Inc. announced its first quarter earnings conference call will be webcast on Tuesday, May 3, 2022 at 8:30 a.m. ET.
-
Zimmer Biomet Debuts WalkAI™ Artificial Intelligence Model to Predict Post-Operative Recovery Progress
3/10/2022
Zimmer Biomet Holdings, Inc., a global medical technology leader, announced the release of WalkAI™, a dynamic artificial intelligence model that identifies patients1 who are predicted to have a lower gait speed outcome at 90 days after hip or knee surgery.
-
Zimmer Biomet Announces Completion of ZimVie Spinoff
3/1/2022
Zimmer Biomet Holdings, Inc., a global medical technology leader, announced that the Company has completed its spinoff of ZimVie, Zimmer Biomet's former Dental and Spine business.
-
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2022
2/22/2022
Zimmer Biomet Holdings, Inc., a global medical technology leader, announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2022.
-
Zimmer Biomet Announces Fourth Quarter and Full-Year 2021 Financial Results
2/7/2022
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2021.
-
Zimmer Biomet Announces Expected Completion Date of March 1, 2022 for Spinoff of ZimVie
2/7/2022
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that its Board of Directors has declared a pro rata dividend of 80.3% of the outstanding common stock of ZimVie Inc.
-
Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of ZimVie; ZimVie to Host Investor Day on February 7
1/21/2022
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that it has filed a Form 10 registration statement with the United States Securities and Exchange Commission ("SEC") in connection with the intended spinoff of its Dental and Spine businesses into a standalone, publicly traded company, ZimVie.
-
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2021 Financial Results
1/10/2022
Zimmer Biomet Holdings, Inc. announced its fourth quarter earnings conference call will be webcast on Monday, February 7, 2022 at 8:30 a.m. ET.
-
Zimmer Biomet to Present at the 40th Annual J.P. Morgan Healthcare Conference
12/28/2021
Zimmer Biomet Holdings, Inc. today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at 3:00 p.m. Eastern Time.
-
Zimmer Biomet Announces Pricing of its Tender Offers for Certain Outstanding Debt Securities
11/30/2021
Approximately $211.48 million in aggregate principal amount of Any and All Notes were validly tendered and not validly withdrawn prior to 5:00 p.m., New York City time, on November 29, 2021 and will be accepted for purchase on the Early Settlement Date.
-
Zimmer Biomet Announces Early Results and Upsize of its Tender Offers for Certain Outstanding Debt Securities
11/30/2021
The Company also announced an increase in the Aggregate Maximum Purchase Price from $1.5 billion to an amount sufficient to purchase all of the Maximum Tender Offer Notes at Acceptance Priority Levels 1 through 2, as set forth in the second table below, that were validly tendered and not validly withdrawn prior to the Early Tender Date.
-
Zimmer Biomet to Present at Evercore ISI's 4th Annual HealthCONx Conference
11/18/2021
Zimmer Biomet Holdings, Inc., a global medical technology leader, announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at Evercore ISI's 4th Annual HealthCONx Conference on Thursday, December 2, 2021, at 1:00 p.m. Eastern Time.
-
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2021
11/16/2021
Zimmer Biomet Holdings, Inc. today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2021.
-
Zimmer Biomet Announces Cash Tender Offers for Certain Outstanding Debt Securities
11/15/2021
Zimmer Biomet Holdings, Inc. announced the commencement of tender offers to purchase for cash any and all of its 3.700% Senior Notes due 2023 and up to $1.5 billion aggregate purchase price of its 3.550% Senior Notes due 2025, 3.550% Senior Notes due 2030, 4.450% Senior Notes due 2045, 3.050% Senior Notes due 2026, 4.250% Senior Notes due 2035 and 5.750% Senior Notes due 2039.